Zura Bio Ownership | Who Owns Zura Bio?
Zura Bio Ownership Summary
Zura Bio is owned by 4.79% institutional investors, 21.54% insiders, and 73.67% retail investors. Suvretta capital management is the largest institutional shareholder, holding 9.63% of ZURA shares. Fidelity Select Biotechnology is the top mutual fund, with 0.54% of its assets in Zura Bio shares.
ZURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Zura Bio | 4.79% | 21.54% | 73.67% |
| Sector | Healthcare Stocks | 35.78% | 11.87% | 52.36% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 9.07M | 9.63% | $53.95M |
| Vr adviser | 6.43M | 6.83% | $38.29M |
| Jpmorgan chase | 4.46M | 4.74% | $25.33M |
| Great point partners | 4.22M | 4.48% | $25.08M |
| Braidwell lp | 3.99M | 4.24% | $23.73M |
| Siren | 3.73M | 3.97% | $22.22M |
| Commodore capital lp | 3.25M | 3.45% | $19.34M |
| Pfizer | 2.84M | 3.02% | $16.83M |
| Adage capital partners gp | 2.75M | 2.92% | $16.36M |
| Affinity asset advisors | 2.56M | 2.72% | $15.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pfizer | 2.84M | 7.05% | $16.83M |
| Great point partners | 4.22M | 5.77% | $25.08M |
| Vr adviser | 6.43M | 1.43% | $38.29M |
| Suvretta capital management | 9.07M | 1.38% | $53.95M |
| Commodore capital lp | 3.25M | 1.12% | $19.34M |
| Stempoint capital lp | 753.52K | 0.87% | $4.48M |
| Saturn v capital management | 739.96K | 0.80% | $4.40M |
| Braidwell lp | 3.99M | 0.79% | $23.73M |
| Affinity asset advisors | 2.56M | 0.79% | $15.26M |
| Boxer capital management | 900.00K | 0.70% | $5.36M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Suvretta capital management | 9.07M | 1.38% | 3.50M |
| Commodore capital lp | 3.25M | 1.12% | 3.25M |
| Siren | 3.73M | 0.62% | 2.43M |
| Cormorant asset management, lp | 1.45M | 0.43% | 1.45M |
| Qvt financial lp | 1.31M | 0.57% | 1.31M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.22M |
| Allostery investments lp | - | - | -2.33M |
| Morgan stanley | 872.95K | 0.00% | -636.46K |
| Woodline partners lp | - | - | -520.28K |
| Sphera funds management | - | - | -421.23K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Commodore capital lp | 3.25M | 1.12% | 3.25M | $19.34M |
| Cormorant asset management, lp | 1.45M | 0.43% | 1.45M | $8.63M |
| Qvt financial lp | 1.31M | 0.57% | 1.31M | $7.80M |
| Ecor1 capital | 1.18M | 0.30% | 1.18M | $7.02M |
| Stempoint capital lp | 753.52K | 0.87% | 753.52K | $4.48M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -14.00 |
| Sterling capital management | -53.00 |
| True wealth design | -78.00 |
| Clearstead advisors | -239.00 |
| Wells fargo & company/mn | -385.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 22 | -72.50% | 4,509,296 | -89.95% | 4 | 0.21% | 10 | -78.26% | 8 | -57.89% |
| Dec 31, 2025 | 35 | -50.70% | 16,505,575 | -59.89% | 17 | 0.92% | 22 | -35.29% | 8 | -65.22% |
| Sep 30, 2025 | 68 | 15.25% | 39,551,293 | 14.18% | 41 | 1.49% | 33 | - | 21 | 31.25% |
| Jun 30, 2025 | 62 | -17.33% | 35,347,572 | -22.51% | 54 | 2.25% | 36 | 20.00% | 16 | -23.81% |
| Mar 31, 2025 | 75 | -18.48% | 45,725,362 | 6.61% | 49 | 2.04% | 31 | -44.64% | 21 | 90.91% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 509.66K | 0.54% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 486.85K | 0.51% | - |
| Fidelity Extended Market Index | 231.28K | 0.24% | -845.00 |
| iShares Micro-Cap ETF | 131.70K | 0.14% | - |
| Blackrock Extended Mkt Fund CF | 117.02K | 0.12% | - |
| BlackRock Extended Equity Market Fund K | 99.64K | 0.10% | 41.39K |
| ALPS Medical Breakthroughs ETF | 88.88K | 0.09% | - |
| Bridgeway Ultra-Small Company | 85.35K | 0.09% | -32.65K |
| Fidelity Total Market Index | 77.98K | 0.08% | 7.31K |
| Extended Equity Market Fund E | 67.92K | 0.07% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 26, 2026 | AI Biotechnology LLC | - | Buy | $12.50M |
| Oct 30, 2023 | Sidhu Someit | - | Buy | $28.52M |
| Nov 25, 2024 | Thiara Parvinder | - | Sell | $2.73M |
| Sep 11, 2024 | Thiara Parvinder | - | Sell | $10.26M |
| Sep 04, 2024 | Sidhu Someit | - | Sell | $200.19K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | 1 | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
ZURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools